Prihlásiť sa Zaregistrujte sa zadarmo

Výnosy Q/Q spoločnosti Midatech Pharma Plc

Aká je hodnota metriky Výnosy Q/Q spoločnosti Midatech Pharma Plc?

Hodnota metriky Výnosy Q/Q spoločnosti Midatech Pharma Plc je -36.32%

Aká je definícia metriky Výnosy Q/Q?

Štvrťročný rast výnosov (Revenue Q/Q) z roku na rok je zvýšenie príjmov firmy v porovnaní s výsledkami v korešpondujúcom štvrťroku minulého roku a vyjadreného v percentách.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Výnosy Q/Q spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Midatech Pharma Plc

Čomu sa venuje spoločnosť Midatech Pharma Plc?

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Firmy s metrikou výnosy q/q podobnou spoločnosti Midatech Pharma Plc